Four things to know:
1. Quarterly sales grew 4.5 percent year-over year, according to a news release.
2. Medtronic’s neuroscience business grew 4.9 percent year-over-year with $2.2 billion in sales. Factors include growth for the Mazor spine robot and StealthStation navigation system.
3. The neuromodulation segment saw mid-single digit growth with strength in the Percept and Intellis devices.
4. Medtronic raised its guidance for fiscal year 2024 and expects full-year revenue growth of 4.5 percent.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.